Universal Beteiligungs und Servicegesellschaft mbH Buys New Position in Ingevity Co. (NYSE:NGVT)

Universal Beteiligungs und Servicegesellschaft mbH acquired a new position in shares of Ingevity Co. (NYSE:NGVT - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund acquired 34,908 shares of the company's stock, valued at approximately $1,423,000. Universal Beteiligungs und Servicegesellschaft mbH owned approximately 0.10% of Ingevity at the end of the most recent quarter.

A number of other institutional investors have also recently added to or reduced their stakes in the stock. Maple Rock Capital Partners Inc. acquired a new position in Ingevity during the fourth quarter worth about $17,515,000. American Century Companies Inc. raised its position in Ingevity by 37.7% during the fourth quarter. American Century Companies Inc. now owns 1,457,365 shares of the company's stock worth $59,388,000 after acquiring an additional 398,800 shares during the last quarter. Vision One Management Partners LP raised its position in Ingevity by 265.0% during the fourth quarter. Vision One Management Partners LP now owns 410,678 shares of the company's stock worth $16,735,000 after acquiring an additional 298,157 shares during the last quarter. Royce & Associates LP raised its position in Ingevity by 22.4% during the fourth quarter. Royce & Associates LP now owns 1,142,598 shares of the company's stock worth $46,561,000 after acquiring an additional 208,921 shares during the last quarter. Finally, Brown Advisory Inc. raised its position in Ingevity by 23.6% during the fourth quarter. Brown Advisory Inc. now owns 928,220 shares of the company's stock worth $37,825,000 after acquiring an additional 177,289 shares during the last quarter. Hedge funds and other institutional investors own 91.59% of the company's stock.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently weighed in on the stock. Wells Fargo & Company boosted their price objective on shares of Ingevity from $32.00 to $38.00 and gave the company an "equal weight" rating in a research report on Wednesday, May 7th. BMO Capital Markets upgraded shares of Ingevity from a "market perform" rating to an "outperform" rating and upped their target price for the company from $62.00 to $65.00 in a research note on Wednesday, February 26th. Finally, Wall Street Zen upgraded shares of Ingevity from a "buy" rating to a "strong-buy" rating in a research note on Friday. One equities research analyst has rated the stock with a hold rating, three have assigned a buy rating and one has issued a strong buy rating to the company's stock. According to data from MarketBeat, the stock has a consensus rating of "Buy" and an average target price of $52.75.

Ingevity Stock Performance

Shares of NGVT stock traded up $0.86 during trading hours on Friday, reaching $42.00. The stock had a trading volume of 187,351 shares, compared to its average volume of 278,306. The company has a debt-to-equity ratio of 6.86, a current ratio of 1.87 and a quick ratio of 1.04. Ingevity Co. has a twelve month low of $28.49 and a twelve month high of $51.67. The firm has a 50-day simple moving average of $36.98 and a 200-day simple moving average of $41.82. The firm has a market capitalization of $1.53 billion, a PE ratio of -3.55 and a beta of 1.39.

Ingevity (NYSE:NGVT - Get Free Report) last released its quarterly earnings data on Wednesday, May 7th. The company reported $0.99 earnings per share for the quarter, topping analysts' consensus estimates of $0.74 by $0.25. Ingevity had a negative net margin of 30.60% and a positive return on equity of 41.44%. The business had revenue of $284.00 million for the quarter, compared to analysts' expectations of $299.13 million. During the same quarter last year, the company earned $0.47 EPS. The company's revenue for the quarter was down 16.5% compared to the same quarter last year. As a group, equities analysts forecast that Ingevity Co. will post 4.45 earnings per share for the current year.

Ingevity Profile

Ingevity Corporation manufactures and sells activated carbon products, derivative specialty chemicals, and engineered polymers in North America, the Asia Pacific, Europe, the Middle East, Africa, and South America. It operates through three segments: Performance Materials, Performance Chemicals, and Advanced Polymer Technologies.